NDAINTRAVENOUSSOLUTION
Approved
Apr 2023
Lifecycle
Growth
Competitive Pressure
0/100
Mechanism of Action
Adrenergic alpha-Agonists
Pharmacologic Class:
alpha-Adrenergic Agonist
Loss of Exclusivity
LOE Date
Mar 21, 2039
158 months away
Patent Expiry
Mar 21, 2039